Parmax Pharma Ltd

PARMAX

Watchlist

AI Mode

‌

Market Cap

₹ 13 Cr

P/E

—

‌

Investment Checklist

How to read checklist?

Performance

STEADY PERFORMER

Valuation

REASONABLE

Growth

STABLE

Profitability

LOW MARGIN

Technicals

Bullish

Risk

LOW RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

Parmax Pharma Ltd, established in 1994, focuses on Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations (CMO).

The company initially manufactured antibiotics and speciality chemicals but discontinued business activities for some years before focusing on the current pharmaceutical operations.

Located in Gujarat, Parmax's antibiotic manufacturing plant has an installed capacity of 96 TPA, highlighting its production potential.

The company's historical expertise lies in manufacturing bulk drugs such as Amoxycillin and Ampicillin, indicating solid foundations in the pharmaceutical industry.

Promoted by industry veterans, Parmax Pharma's strategic decisions showed resilience and adaptability in a challenging business landscape.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Bulk Drugs

Market Cap

13 Cr

Volatility

Low Risk

P/E Ratio

—

Industry P/E

59.2

PEG Ratio

—

P/B Ratio

—

52W High

55.02

52W Low

28.00

Sales CAGR

155.20%

15.61%

6.14%

10Y

—

Profit CAGR

63.65%

—

10Y

—

ROE

TTM

75.76%

-200.09%

-44.78%

10Y

-16.76%

ROCE

TTM

-46.38%

-28.82%

-9.40%

10Y

-3.83%

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
GODAVARI	71.53	54 Cr	12.38	1.24	0.00	8.16	7.47	2.28
ROOPAIND	47.35	37 Cr	19.33	2.04	0.00	10.56	10.48	2.22
VILINBIO	19.90	28 Cr	124.38	1.20	0.00	1.08	3.59	1.00
ISHITADR	74.79	22 Cr	22.21	1.92	0.00	8.65	10.56	6.66
CHEMOPH	134.70	19 Cr	—	13.44	0.00	-850.15	-830.59	-593.20
VENMAX	27.87	15 Cr	42.23	2.51	0.00	4.02	3.11	2.49
PARMAX	33.64	13 Cr	—	0.00	0.00	75.76	-46.38	-26.77

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	1.40	4.07	1.33	4.26	7.82	9.28	6.28	4.83	1.94	2.53
Expenses	2.05	4.83	2.48	5.05	7.30	9.08	6.18	5.39	2.19	4.12
Operating Profit	-0.65	-0.76	-1.15	-0.79	0.52	0.20	0.10	-0.56	-0.25	-1.59
OPM %	-46.43	-18.67	-86.47	-18.54	6.65	2.16	1.59	-11.59	-12.89	-62.85
Other Income	0.01	0.01	0.01	0.01	0.01	0.12	0.01	-1.17	0.01	0.01
Interest	0.12	0.18	0.16	0.16	0.11	0.13	0.11	0.24	0.28	0.24
Depreciation	0.42	0.43	0.45	0.41	0.40	0.40	0.41	-0.18	0.24	0.26
Profit Before Tax	-1.18	-1.37	-1.75	-1.36	0.01	-0.22	-0.39	-1.80	-0.76	-2.08
Tax %	0.00	0.00	0.00	-6.62	0.00	0.00	0.00	16.67	0.00	0.00
Net Profit	-1.18	-1.37	-1.75	-1.45	0.01	-0.22	-0.39	-1.49	-0.76	-2.08
EPS in Rs	-3.15	-3.66	-4.68	-3.88	0.03	-0.58	-1.05	-4.00	-2.04	-5.56

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	0.00	12	12	21	26	18	15	11	28	22
Expenses	0.05	11	11	19	23	16	13	14	28	23
Operating Profit	-0.05	1.08	1.13	1.78	3.42	2.56	2.25	-3.37	0.25	-0.51
OPM %	—	9.08	9.41	8.51	13.03	14.01	14.61	-30.50	0.90	-2.28
Other Income	0.06	0.05	0.05	0.10	0.09	0.06	0.04	0.05	-1.03	-1.03
Interest	0.00	0.03	0.03	0.13	0.35	0.39	0.37	0.62	0.59	0.76
Depreciation	0.00	1.09	1.03	1.01	1.94	1.93	1.88	1.71	1.03	0.87
Profit Before Tax	0.01	0.00	0.10	0.73	1.21	0.30	0.05	-5.66	-2.40	-3.17
Tax %	253.85	67.20	19.80	41.33	37.57	53.34	325.63	-2.17	12.57	9.78
Net Profit	-0.01	0.00	0.08	0.43	0.75	0.14	-0.10	-5.78	-2.09	-2.86
EPS in Rs	0.01	0.01	0.21	1.15	2.04	0.39	-0.28	-15.37	-5.60	-12.65
Dividend Payout %	0.00	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	4.45	4.45	4.45	4.45	4.45	4.45	4.45	4.45	4.45	4.45
Reserves	0.11	0.10	0.11	0.18	0.61	1.37	1.51	1.40	-4.38	-6.44
Borrowings	0.46	1.02	2.16	5.26	5.03	5.43	4.52	4.48	5.91	7.70
Other Liabilities	0.05	2.13	9.91	9.82	11	11	7.49	7.28	9.35	13
Total Liabilities	5.08	7.71	17	20	21	23	18	18	15	19
Fixed Assets	2.53	2.72	5.86	4.92	9.64	11	10	9.50	9.27	7.97
CWIP	0.00	0.00	0.00	3.33	0.00	0.00	0.00	0.00	0.10	0.00
Investments	0.00	0.00	0.00	0.20	0.20	0.20	0.00	0.00	0.00	0.40
Other Assets	2.54	4.99	11	11	11	12	7.53	8.11	5.95	10
Total Assets	5.08	7.71	17	20	21	23	18	18	15	19

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	-0.00	-0.50	3.88	0.92	2.82	3.53	0.75	0.33	-0.19	-0.96
Cash from Investing Activity	0.00	-0.19	-4.23	-3.41	-2.40	-3.15	-1.53	-0.94	-1.59	-0.70
Cash from Financing Activity	0.10	0.56	1.14	3.10	-0.23	0.40	-0.91	-0.04	1.43	1.40
Net Cash Flow	0.09	-0.14	0.79	0.61	0.20	0.78	-1.69	-0.65	-0.35	-0.26

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	30.80%	30.80%	30.80%	30.80%	30.80%	30.83%	30.80%	30.80%	30.80%	30.80%	30.80%	30.80%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	69.20%	69.20%	69.20%	69.20%	69.20%	69.17%	69.20%	69.20%	69.20%	69.20%	69.20%	69.20%
Total Shareholders	2,035	1,997	1,978	1,973	2,002	2,099	2,185	2,246	2,334	2,356	2,377	2,399

Projection

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	1.40	4.07	1.33	4.26	7.82	9.28	6.28	4.83	1.94	2.53
Expenses	2.05	4.83	2.48	5.05	7.30	9.08	6.18	5.39	2.19	4.12
Operating Profit	-0.65	-0.76	-1.15	-0.79	0.52	0.20	0.10	-0.56	-0.25	-1.59
OPM %	-46.43	-18.67	-86.47	-18.54	6.65	2.16	1.59	-11.59	-12.89	-62.85
Other Income	0.01	0.01	0.01	0.01	0.01	0.12	0.01	-1.17	0.01	0.01
Interest	0.12	0.18	0.16	0.16	0.11	0.13	0.11	0.24	0.28	0.24
Depreciation	0.42	0.43	0.45	0.41	0.40	0.40	0.41	-0.18	0.24	0.26
Profit Before Tax	-1.18	-1.37	-1.75	-1.36	0.01	-0.22	-0.39	-1.80	-0.76	-2.08
Tax %	0.00	0.00	0.00	-6.62	0.00	0.00	0.00	16.67	0.00	0.00
Net Profit	-1.18	-1.37	-1.75	-1.45	0.01	-0.22	-0.39	-1.49	-0.76	-2.08
EPS in Rs	-3.15	-3.66	-4.68	-3.88	0.03	-0.58	-1.05	-4.00	-2.04	-5.56

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	0.00	12	12	21	26	18	15	11	28	22
Expenses	0.05	11	11	19	23	16	13	14	28	23
Operating Profit	-0.05	1.08	1.13	1.78	3.42	2.56	2.25	-3.37	0.25	-0.51
OPM %	—	9.08	9.41	8.51	13.03	14.01	14.61	-30.50	0.90	-2.28
Other Income	0.06	0.05	0.05	0.10	0.09	0.06	0.04	0.05	-1.03	-1.03
Interest	0.00	0.03	0.03	0.13	0.35	0.39	0.37	0.62	0.59	0.76
Depreciation	0.00	1.09	1.03	1.01	1.94	1.93	1.88	1.71	1.03	0.87
Profit Before Tax	0.01	0.00	0.10	0.73	1.21	0.30	0.05	-5.66	-2.40	-3.17
Tax %	253.85	67.20	19.80	41.33	37.57	53.34	325.63	-2.17	12.57	9.78
Net Profit	-0.01	0.00	0.08	0.43	0.75	0.14	-0.10	-5.78	-2.09	-2.86
EPS in Rs	0.01	0.01	0.21	1.15	2.04	0.39	-0.28	-15.37	-5.60	-12.65
Dividend Payout %	0.00	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	4.45	4.45	4.45	4.45	4.45	4.45	4.45	4.45	4.45	4.45
Reserves	0.11	0.10	0.11	0.18	0.61	1.37	1.51	1.40	-4.38	-6.44
Borrowings	0.46	1.02	2.16	5.26	5.03	5.43	4.52	4.48	5.91	7.70
Other Liabilities	0.05	2.13	9.91	9.82	11	11	7.49	7.28	9.35	13
Total Liabilities	5.08	7.71	17	20	21	23	18	18	15	19
Fixed Assets	2.53	2.72	5.86	4.92	9.64	11	10	9.50	9.27	7.97
CWIP	0.00	0.00	0.00	3.33	0.00	0.00	0.00	0.00	0.10	0.00
Investments	0.00	0.00	0.00	0.20	0.20	0.20	0.00	0.00	0.00	0.40
Other Assets	2.54	4.99	11	11	11	12	7.53	8.11	5.95	10
Total Assets	5.08	7.71	17	20	21	23	18	18	15	19

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	-0.00	-0.50	3.88	0.92	2.82	3.53	0.75	0.33	-0.19	-0.96
Cash from Investing Activity	0.00	-0.19	-4.23	-3.41	-2.40	-3.15	-1.53	-0.94	-1.59	-0.70
Cash from Financing Activity	0.10	0.56	1.14	3.10	-0.23	0.40	-0.91	-0.04	1.43	1.40
Net Cash Flow	0.09	-0.14	0.79	0.61	0.20	0.78	-1.69	-0.65	-0.35	-0.26

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
GODAVARI	71.53	54 Cr	12.38	1.24	0.00	8.16	7.47	2.28
ROOPAIND	47.35	37 Cr	19.33	2.04	0.00	10.56	10.48	2.22
VILINBIO	19.90	28 Cr	124.38	1.20	0.00	1.08	3.59	1.00
ISHITADR	74.79	22 Cr	22.21	1.92	0.00	8.65	10.56	6.66
CHEMOPH	134.70	19 Cr	—	13.44	0.00	-850.15	-830.59	-593.20
VENMAX	27.87	15 Cr	42.23	2.51	0.00	4.02	3.11	2.49
PARMAX	33.64	13 Cr	—	0.00	0.00	75.76	-46.38	-26.77

Oscillators

BearishNeutralBullish

Neutral

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Overview

Detailed Summary

Parmax Pharma Ltd, established in 1994, focuses on Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations (CMO).

The company initially manufactured antibiotics and speciality chemicals but discontinued business activities for some years before focusing on the current pharmaceutical operations.

Located in Gujarat, Parmax's antibiotic manufacturing plant has an installed capacity of 96 TPA, highlighting its production potential.

The company's historical expertise lies in manufacturing bulk drugs such as Amoxycillin and Ampicillin, indicating solid foundations in the pharmaceutical industry.

Promoted by industry veterans, Parmax Pharma's strategic decisions showed resilience and adaptability in a challenging business landscape.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Bulk Drugs

Market Cap

13 Cr

Volatility

Low Risk

P/E Ratio

—

Industry P/E

59.2

PEG Ratio

—

P/B Ratio

—

52W High

55.02

52W Low

28.00

Sales CAGR

155.20%

15.61%

6.14%

10Y

—

Profit CAGR

63.65%

—

10Y

—

ROE

TTM

75.76%

-200.09%

-44.78%

10Y

-16.76%

ROCE

TTM

-46.38%

-28.82%

-9.40%

10Y

-3.83%